Meeder Asset Management Inc Twist Bioscience Corp Transaction History

Meeder Asset Management Inc

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$14.6 - $30.9 $943,568 - $2 Million	-64,628 Reduced 98.08%	1,262 $19,000
Q4 2022 Feb 14, 2023	BUY	$21.92 - $39.37 $1.44 Million - $2.59 Million	65,672 Added 30124.77%	65,890 $1.57 Million
Q3 2022 Nov 14, 2022	BUY	$33.44 - $56.56 $6,052 - $10,237	181 Added 489.19%	218 $8,000
Q2 2022 Aug 08, 2022	BUY	$26.2 - $54.0 $969 - $1,998	37 New	37 $1,000
Q4 2021 Feb 11, 2022	SELL	$75.47 - $135.88 $248,598 - $447,588	-3,294 Closed	0 $0
Q3 2021 Nov 08, 2021	SELL	$95.64 - $131.48 $3,538 - $4,864	-37 Reduced 1.11%	3,294 $352,000
Q2 2021 Aug 09, 2021	BUY	$88.13 - $142.06 $93,329 - $150,441	1,059 Added 46.61%	3,331 $444,000
Q1 2021 Apr 28, 2021	BUY	$105.48 - $207.97 $239,650 - $472,507	2,272 New	2,272 $282,000
Q4 2020 Feb 09, 2021	SELL	$76.64 - $167.89 $86,679 - $189,883	-1,131 Closed	0 $0
Q3 2020 Nov 02, 2020	BUY	$45.46 - $78.79 $42,459 - $73,589	934 Added 474.11%	1,131 $87,000
Q2 2020 Aug 11, 2020	SELL	$26.4 - $45.3 $31,680 - $54,360	-1,200 Reduced 85.9%	197 $9,000
Q1 2020 May 15, 2020	BUY	$19.71 - $35.15 $27,534 - $49,104	1,397 New	1,397 $43,000

270

67.2M

118K

40.2K

Ticker TWST
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 56,363,500
Market Cap $2.29B
Description
Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for d...

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Meeder Asset Management Inc with notifications on news.